Physician profile
John C Pickard
NPI 1417996612
$919.02
in general payments reported to CMS, 2019-2025
17 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $90.23 · 2021: $47.03 · 2022: $159 · 2023: $146 · 2024: $58.20 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.53 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $139.20 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $103.45 | 2019-2022 | |
| Abbott Laboratories | $95.48 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $78.53 | 2019-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $57.62 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.20 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $49.80 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.67 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $37.94 | 2023-2025 | Gemtesa |
| Mylan Specialty L.P. | $28.12 | 2021 | |
| Amarin Pharma, INC. | $22.47 | 2019 | |
| Optinose US, INC. | $12.35 | 2019 | |
| Seqirus USA INC | $11.95 | 2019 | |
| Merck Sharp & Dohme LLC | $11.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11.93 | 2019 | |
| Allergan, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pickard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.